Stockreport

Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway [Yahoo! Finance]

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK Oct. 15, 2024 HT-ALZ represents a breakthrough in Alzheimer's treatment, specifically targeting the Substance P/Neurokinin-1 Receptor pathway. This pathway i [Read more]